Memorial Sloan Kettering Cancer Center, New York, NY.
Weill Cornell Medical College, New York, NY.
Pediatr Blood Cancer. 2018 Nov;65(11):e27304. doi: 10.1002/pbc.27304. Epub 2018 Jul 15.
Childhood cancer survivors exposed to abdominal radiation (abdRT) are at increased risk for both insulin-dependent and non-insulin-dependent diabetes. We sought to clarify the pathophysiology of diabetes after abdRT by performing dynamic studies of insulin and glucose and testing for type 1 diabetes-associated autoantibodies.
Cross-sectional analysis of 2-year childhood cancer survivors treated with abdRT at age ≤21 years who underwent oral glucose tolerance testing and assessment of diabetes-related autoantibodies from December 2014 to September 2016. Prevalence of insulin/glucose derangements, indices of insulin sensitivity/secretion (homeostatic model assessment of insulin resistance [HOMA-IR], whole-body insulin sensitivity, insulinogenic index), autoantibody positivity, and treatment/demographic factors associated with adverse metabolic outcomes were assessed.
Among 40 participants previously exposed to abdRT (57.5% male; median age at cancer diagnosis, 3.3 years [range, 0.5-20.1]; median age at study 14.3 years [range, 8.3-49.8]; none with obesity), 9 (22.5%) had glucose derangements (n = 4 with impaired fasting glucose [≥100 mg/dL]; n = 4 with impaired glucose tolerance [2-hour glucose 140-199 mg/dL]; n = 1 with previously unrecognized diabetes [2-hour glucose ≥200 mg/dL]). Three of the four individuals with impaired fasting glucose also had insulin resistance, as measured by HOMA-IR; an additional four subjects with normal glucose tolerance were insulin resistant. The subject with diabetes had normal HOMA-IR. No participant had absolute insulinopenia or >1 positive diabetes-related autoantibody.
This study suggests that radiation-induced damage to the insulin-producing β-cells is an unlikely explanation for the early derangements in glucose metabolism observed after abdRT. Research into alternative pathways leading to diabetes after abdRT is needed.
接受腹部放射治疗(abdRT)的儿童癌症幸存者患胰岛素依赖型和非胰岛素依赖型糖尿病的风险增加。我们通过进行胰岛素和葡萄糖的动态研究,并检测 1 型糖尿病相关自身抗体,旨在阐明 abdRT 后糖尿病的病理生理学。
对 2014 年 12 月至 2016 年 9 月期间接受 abdRT 治疗且年龄≤21 岁的 2 年儿童癌症幸存者进行横断面分析,这些患者接受了口服葡萄糖耐量试验和糖尿病相关自身抗体检测。评估胰岛素/葡萄糖紊乱、胰岛素敏感性/分泌指数(稳态模型评估的胰岛素抵抗指数[HOMA-IR]、全身胰岛素敏感性、胰岛素生成指数)、自身抗体阳性率以及与不良代谢结局相关的治疗/人口统计学因素的患病率。
在 40 名先前接受过 abdRT 暴露的参与者中(57.5%为男性;癌症诊断时的中位年龄为 3.3 岁[范围,0.5-20.1];研究时的中位年龄为 14.3 岁[范围,8.3-49.8];均无肥胖),9 名(22.5%)存在葡萄糖紊乱(n=4 名空腹血糖受损[≥100mg/dL];n=4 名葡萄糖耐量受损[2 小时血糖 140-199mg/dL];n=1 名以前未确诊的糖尿病[2 小时血糖≥200mg/dL])。其中 4 名空腹血糖受损者的 HOMA-IR 也存在胰岛素抵抗;另外 4 名血糖正常者的胰岛素抵抗。患有糖尿病的患者 HOMA-IR 正常。无参与者存在绝对胰岛素缺乏或 1 种以上阳性糖尿病相关自身抗体。
本研究表明,辐射引起的胰岛素产生β细胞损伤不太可能是 abdRT 后观察到的葡萄糖代谢早期紊乱的原因。需要对 abdRT 后导致糖尿病的其他途径进行研究。